Promising Antineoplastic Actions of Melatonin

Area of Science:

• Oncology
• Endocrinology
• Molecular Biology

Background:

• Melatonin is an endogenous indoleamine with diverse biological activities.
• Emerging research highlights melatonin's significant interactions with cancerous cells.
• Its role in cancer therapy is a rapidly growing area of scientific interest.

Purpose of the Study:

• To synthesize current knowledge on melatonin's antineoplastic actions.
• To evaluate melatonin's potential as a therapeutic agent against neoplastic diseases.
• To consolidate findings on melatonin's effects on cancer cell proliferation, metastasis, and apoptosis.

Main Methods:

• Review of existing scientific literature on melatonin and cancer.
• Analysis of studies investigating melatonin's effects on cancer cell proliferation and receptor expression.
• Examination of research on melatonin's differential apoptotic effects in normal versus cancerous cells.

Main Results:

• Melatonin enhances the efficacy of various chemotherapy drugs.
• It exhibits direct inhibitory effects on neoplastic cell proliferation and metastasis.
• Melatonin demonstrates pro-apoptotic effects in cancer cells, contrasting with its anti-apoptotic role in normal cells.

Conclusions:

• Melatonin possesses multifaceted antineoplastic properties.
• Its ability to suppress cancer growth, reduce metastasis, and induce cancer cell apoptosis warrants further investigation.
• Melatonin holds significant potential for integration into cancer treatment strategies.